Clinical Investigation of the Safety of the MediSieve Magnetic Haemofiltration System in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 13, 2022

Primary Completion Date

November 17, 2022

Study Completion Date

November 30, 2022

Conditions
Haemofiltration
Interventions
DEVICE

MediSieve Magnetic Haemofiltration System

The MediSieve Magnetic Haemofiltration System is a medical device intended for use in extracorporeal clinical procedures to remove magnetic targets (e.g. malaria infected red blood cells) from a patient's bloodstream. Healthy volunteers will undergo filtration for 5 hours.

Trial Locations (1)

6525GA

Radboud University Medical Center, Nijmegen

All Listed Sponsors
collaborator

Radboud University Medical Center

OTHER

lead

MediSieve Limited

INDUSTRY